Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

PierianDx

PierianDx
2014 FOUNDED
PRIVATE STATUS
61-70 EMPLOYEES
Early Stage VC LATEST DEAL TYPE
$3.05M LATEST DEAL AMOUNT
8 INVESTORS
Description

Provider of a cloud-based clinical genomics software platform designed to simplify genomic insights in order to make precision medicine possible.The company's clinical genomics software platform uses automated actionable Intelligence and simplifies the process of taking DNA sequencing data though analysis, interpretation and final report, enabling the healthcare industry to save more lives with advanced precision medicine.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Other Healthcare Services
Other Software
Primary Office
  • 77 Maryland Plaza
  • Saint Louis, MO 63108
  • United States

+1 (314) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore PierianDx’s full profile, request a free trial.

PierianDx Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Early Stage VC 09-Feb-2018 $3.05M 000.00 Completed Generating Revenue
1. Early Stage VC (Series A) 08-Dec-2015 000.00 000.00 000.00 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

PierianDx Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 0,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

PierianDx Competitors (12)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Genedata Venture Capital-Backed Basel, Switzerland 000 000000 - 000
0000000 Venture Capital-Backed Rijswijk, Netherlands 00 000.00 00000000000 000.00
00000 00000000 Venture Capital-Backed Cambridge, United Kingdom 00.000 000000000000 00.000
000000000 Corporation Cambridge, United Kingdom 00 0000000000
00000000000 000000 Venture Capital-Backed Palo Alto, CA 000 00000 0000000000 0 00000
To view this company’s complete list of competitors, request access »

PierianDx Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000 00000000 12-Oct-2016 000000000000000000 Social/Platform Software 000 0000000 00.0
To view this company’s complete investment and acquisition history, request access »

PierianDx Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Peak Ventures Venture Capital Minority 000 0000 000000 0
TLSG Investments Venture Capital Minority 000 0000 000000 0
ARUP Laboratories Corporation Minority 000 0000 000000 0
Health Catalyst Capital Management Venture Capital Minority 000 0000 000000 0
Inova Health System Corporation Minority 000 0000 000000 0
You’re viewing 5 of 8 investors. Get the full list »

PierianDx Executive Team (14)

Name Title Board
Seat
Contact
Info
Michael Sanderson Chief Executive Officer & Director of the Board
Chris Callahan Chief Operating Officer & Executive Vice President
Joshua Forsythe Vice President, Marketing
Andy Bredemeyer Ph.D Vice President, Product
Mukesh Sharma Ph.D Vice President, Product

7 Former Executives

You’re viewing 5 of 14 executives. Get the full list »

PierianDx Board Members (8)

Name Representing Role Since Contact
Info
Bryan Carey Health Catalyst Capital Management Board Member 000 0000
Charles Boorady Health Catalyst Capital Management Board Member 000 0000
Frederick Hessler Self Board Member 000 0000
John Niederhuber MD PierianDx Board Member 000 0000
Peter Jobse Inova Strategic Investments Board Member 000 0000

1 Former Board Member

You’re viewing 5 of 8 board members. Get the full list »